Assorted news from the last week:
The International Cancer Research Partnership (ICRP) published results from its Impact of Covid-19 on childhood cancer research funding organizations survey
More news about the effect of Covid-19 on cancer research (all types, not just pediatric and AYA).
A team of scientists at Texas A&M University have developed a way to more accurately both detect and monitor a common type of pediatric brain cancer, setting the stage for giving clinicians a real-time view into how the cancer responds to treatment.
Researchers at the University of Michigan have demonstrated that a new liquid biopsy approach overcomes traditional barriers to quickly and efficiently diagnose and monitor high-grade pediatric gliomas.
U.S. News & World Reports this week reported on a new study that explores what affect repealing Obamacare, or the Affordable Care Act (ACA), would have on pediatric cancer patients.
The AREN0321 trial (ClinicalTrials.gov Identifier: NCT03595124), the first-ever prospective study of pediatric renal cell carcinoma (RCC), determined that unlike in adult RCC, complete surgical removal of the tumor produced favorable outcomes, regardless of lymph node status.
The Childhood Cancer: Cross-Sector Strategies for Prevention report was recently translated into Spanish. Si eres nuevo, consulta el informe y mira como estamos trabajando para prevenir El Cáncer Infantil http://bit.ly/
If you’re new, check out the report and see how we’re working to prevent Childhood Cancer http://bit.ly/
Upcoming webinars and Online Opportunities:
Children’s Cancer Cause will present a free community webinar entitled Elevating the Needs of Childhood Cancer Survivors on Wednesday, October 28 at 11:00ET.
Clouds centering on the life of Zach Sobiech debuts on Disney+ on Oct. 16. Read the back story and get CAC2 Member Laura Sobiech’s perspective on making the movie of Zach’s life, and view the trailer.
Neuroblastoma Parent Global Symposium on November 6th and 7th, 2020 offers a free, online, 2-day event that will bring together families directly affected by neuroblastoma around the world with those who work to treat, help and support them. Researchers and clinicians will lead sessions to provide information on current treatments around the world and share emerging therapies. Registration is now open to reserve a space for this free event!